Andrew Agbarakwe

I am a London based experienced SCRA with over 25 yrs experience in a variety of therapeutic areas including oncology, cardiology, asthma, dentistry, transplantation, and across all phases. I currently work as at MAC clinical research and I  have always worked well in smaller organisations where I feel my contribution is more recognised and highly appreciated. I believe my experience will add great value to any company and my personality and skill set a great asset to any team. 

I am looking for a role that offers stability and long term prospects.

I have been working in clinical research since 1994 in various CROs and Pharmaceutical companies.  From 1994 to 1996 I worked at Chiltern International UK as a CRA.  Between 1997 and 2006 I continued at Chiltern as SCRA/ LCRA in a number of therapeutic areas primarily cardiovascular, neurology, GI, dentistry and asthma. In 1997 I began contracting with Roche Products as Country Study Manager/Monitor where I managed studies in various therapeutic areas such as Rheumatoid Arthritis, Metastatic Breast Cancer, Paeds Renal Transplantation, Lung transplantation, Liver transplantation Phase II/III,  From 2006 to 2007 he collaborated with various CROs such as Pharmanet Limited, Hamell Communications Ltd. and Elan Pharma Limited as SCRA conducting monitoring activities in studies involving Hypercholesterolemia (Phase III), Migraine (Phase IV), Benign Prostatic Hyperplasia (Phase IV), Alzheimer’s Disease (Phase IIa).  In 2007, I joined Pfizer UK as Clinical Research Site Manager conducting monitoring activities from Investigator selection to close-out visits and also acted as Mentor to junior staff. I worked in Phase I and II studies in Asthma, NSCLC, Cardiology, Crohn’s disease and Ulcerative Colitis.  In 2011, I moved to ICON UK as contract SCRA and worked on an Alzheimers study and also worked with Quintiles in 2010 as contract SCRA managing and monitoring sites including financial management of various studies eg Acute COPD and Acute Myeloid Leukaemia (Phase I, III), Cardiology (Phase III).  From 2013 to 2021, I continued to work as contract SCRA in companies such as Clinipace, Cromsource, INC, Regeneron, Biotrial, Alimentiv, Piqur in a wide range of therapeutic areas in Phase II Multiple Myeloma, Phase I Lymphoma/Solid tumour, Phase IV Pouchitis, Phase II Ulcerative Colitis, just to name a few.  Before joining Pivotal as SCRA, I worked at PPD UK in Phase II/III study for COVID 19 handling remote monitoring activities, monitoring safety data review and data query resolutions, PSV activities and site set up.

I am a Senior Clinical Research Associate with more than 20 years of experience in the clinical research industry in different positions, including CRA, Senior CRA, Country Study Manager and Project Leader in numerous therapeutic areas and across all phases (I- IV).

I have performed all types of on-site and remote Monitoring Visits: PSV, SIV, IMV and COV with 100% or reduced SDV and rSDR. I have used different clinical and/or client specific systems for trial management, such as EDC, CTMS, IVRS and participated in several site sponsor audits, local authority inspections and supported investigative site in preparation for an MHRA inspection